NL (n = 75) | NAFL (n = 56) | NASH (n = 59) | |
---|---|---|---|
Age (years) | 46.58 ± 14.11 | 52.51 ± 14.15* | 55.42 ± 11.1*** |
Gender (female/male, %) | 13.33 / 86.67 | 33.9 / 66.1 | 44.07 / 55.93 |
BMI (kg/m2) | 27.57 ± 5.1 | 28.46 ± 3.96 | 34.14 ± 6.56***### |
Glucose (mg/dL) | 92.6 ± 19.46 | 99.23 ± 13.92*** | 119.35 ± 48.5*** |
Insulin (μU/L) | 7.67 ± 4.44 | 10.06 ± 5.36** | 21.38 ± 15.11***### |
HOMA-IR | 1.83 ± 1.31 | 2.52 ± 1.53*** | 6.19 ± 4.92***### |
Triglycerides (mg/dL) | 122.33 ± 66.78 | 135.52 ± 56.47* | 176.22 ± 120.84***## |
Total cholesterol (mg/dL) | 191.17 ± 38.48 | 203.96 ± 39.13 | 192.44 ± 45.29 |
AST (IU/L) | 17.96 ± 5.69 | 21.59 ± 8.65* | 42.12 ± 25.95***### |
ALT (IU/L) | 18.52 ± 10.1 | 27.12 ± 17.27*** | 54.73 ± 33.02***### |
GGT (IU/L) | 32.36 ± 29.51 | 48.82 ± 52.26** | 117.24 ± 194.33***### |
Steatosis (%) | |||
Grade 0 | 100% | 8.5% | |
Grade 1 | 73.21% | 28.8% | |
Grade 2 | 17.86% | 33.9% | |
Grade 3 | 8.93% | 28.8% | |
Ballooning and lobular inflammation (%) | |||
Grade 0 | 100% | 87.5% | 1.85% |
Grade 1 | 12.5% | 37.04% | |
Grade 2 | 51.85% | ||
Grade 3 | 9.26% | ||
Fibrosis (%) | |||
Grade 0 | 100% | 100% | 13.56% |
Grade 1 | 35.6% | ||
Grade 2 | 18.64% | ||
Grade 3 | 20.34% | ||
Grade 4 | 11.86% |